# A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects

> **NCT03229291** · PHASE1 · COMPLETED · sponsor: **Biosplice Therapeutics, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Tendinopathy

## Interventions

- **DRUG:** SM04755
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT03229291
- **Lead sponsor:** Biosplice Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-03
- **Primary completion:** 2017-06-11
- **Final completion:** 2017-06-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03229291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03229291, "A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03229291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*